thymoquinone has been researched along with Astrocytoma, Grade IV in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kacar, S; Kutlu, HM; Sahinturk, V; Tomsuk, O | 1 |
Gao, J; Kang, ZF; Mai, A; Ting, WJ; Tu, JY; Yao, QM; Ye, SW | 1 |
Khazaei, M; Pazhouhi, M | 1 |
Akbor, MM; Bin Sayeed, MS; Chowdhury, FA; Hossain, MK; Mostofa, AGM | 1 |
Kaur, B; Meisen, WH; Racoma, IO; Wang, QE; Wani, AA | 1 |
Angeletti, M; Bonfili, L; Bramucci, M; Cecarini, V; Cuccioloni, M; Di Blasio, A; Eleuteri, AM; Lupidi, G; Mozzicafreddo, M; Quassinti, L | 1 |
Baskar, R; Gurung, RL; Hande, MP; Jayapal, M; Khaw, AK; Lim, SN; Mohamed Ali, S; Sethu, S; Shenoy, K; Soon, JF | 1 |
Abusnina, A; Boukhari, A; Gies, JP; Kolli-Bouhafs, K; Lugnier, C; Rondé, P; Velot, E | 1 |
1 review(s) available for thymoquinone and Astrocytoma, Grade IV
Article | Year |
---|---|
Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzoquinones; Blood-Brain Barrier; Brain Neoplasms; Glioblastoma; Humans; Nigella sativa | 2018 |
7 other study(ies) available for thymoquinone and Astrocytoma, Grade IV
Article | Year |
---|---|
The effects of thymoquinone and quercetin on the toxicity of acrylamide in rat glioma cells.
Topics: Acrylamide; Animals; Annexin A5; Apoptosis; Benzoquinones; Caspase 3; Glioblastoma; Glioma; NF-E2-Related Factor 2; Oxidative Stress; Quercetin; Rats | 2022 |
Thymoquinone induces apoptosis in temozolomide-resistant glioblastoma cells via the p38 mitogen-activated protein kinase signaling pathway.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Glioblastoma; Guanine; Mice; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Purines; Signal Transduction; Temozolomide | 2023 |
Temozolomide-Mediated Apoptotic Death Is Improved by Thymoquinone in U87MG Cell Line.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzoquinones; Brain Neoplasms; Cell Line, Tumor; Comet Assay; Cytochromes c; Dacarbazine; Drug Synergism; Glioblastoma; Glutathione; Humans; In Situ Nick-End Labeling; Membrane Potential, Mitochondrial; Nitric Oxide; Reactive Oxygen Species; Staining and Labeling; Temozolomide | 2017 |
Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Benzoquinones; Caspases; Cathepsins; Cell Death; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Glioblastoma; Humans; Intracellular Membranes; Lysosomes; Models, Biological; Permeability | 2013 |
Effects of thymoquinone on isolated and cellular proteasomes.
Topics: bcl-2-Associated X Protein; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Molecular Structure; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Tumor Suppressor Protein p53 | 2010 |
Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Brain; Cell Line, Tumor; Cell Survival; Cytochromes c; DNA Damage; DNA Repair; DNA-Activated Protein Kinase; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Nuclear Proteins; Telomerase; Telomere | 2010 |
Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation.
Topics: Antineoplastic Agents, Phytogenic; Benzoquinones; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Movement; Down-Regulation; Fibroblasts; Focal Adhesion Kinase 1; Glioblastoma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Nigella sativa | 2012 |